Browsing Tag
University of Southern California
1 post
Can a nasal therapy bypass the blood-brain barrier? NEO100’s Phase 2a data offer an early answer
NEO100 posts 48.9% six-month PFS and 26-month median survival, but NeOnc’s $2m cash balance puts funding and FDA strategy in focus.